Comment on Why a Durham CEO calls potential $2.7 billion deal with big pharma 'transformational'

Why a Durham CEO calls potential $2.7 billion deal with big pharma 'transformational'

For a drug startup that went public a year ago, an influx of cash or deal with a major pharmaceutical company can be groundbreaking, but for a Triangle gene therapy firm that just inked a deal worth up to $2.7 billion, the CEO calls it "transformational."

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News